Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials recruiting in North Carolina

Fewer than 3 recruiting trials found.

All Metastatic Hormone-sensitive Prostate Cancer (mHSPC) trials nationally

1

Recruiting in North Carolina

1

Cities with sites

Cities in North Carolina

Durham 1

Recruiting trials in North Carolina

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
NCT07190300 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: Male · North Carolina: Durham

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.